Cargando…
Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel
AIMS: To appraise the clinical and genetic evidence that low-density lipoproteins (LDLs) cause atherosclerotic cardiovascular disease (ASCVD). METHODS AND RESULTS: We assessed whether the association between LDL and ASCVD fulfils the criteria for causality by evaluating the totality of evidence from...
Autores principales: | Ference, Brian A., Ginsberg, Henry N., Graham, Ian, Ray, Kausik K., Packard, Chris J., Bruckert, Eric, Hegele, Robert A., Krauss, Ronald M., Raal, Frederick J., Schunkert, Heribert, Watts, Gerald F., Borén, Jan, Fazio, Sergio, Horton, Jay D., Masana, Luis, Nicholls, Stephen J., Nordestgaard, Børge G., van de Sluis, Bart, Taskinen, Marja-Riitta, Tokgözoğlu, Lale, Landmesser, Ulf, Laufs, Ulrich, Wiklund, Olov, Stock, Jane K., Chapman, M. John, Catapano, Alberico L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5837225/ https://www.ncbi.nlm.nih.gov/pubmed/28444290 http://dx.doi.org/10.1093/eurheartj/ehx144 |
Ejemplares similares
-
Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European Atherosclerosis Society Consensus Panel
por: Borén, Jan, et al.
Publicado: (2020) -
Statin-associated muscle symptoms: impact on statin therapy—European Atherosclerosis Society Consensus Panel Statement on Assessment, Aetiology and Management
por: Stroes, Erik S., et al.
Publicado: (2015) -
Triglyceride-rich lipoproteins and their remnants: metabolic insights, role in atherosclerotic cardiovascular disease, and emerging therapeutic strategies—a consensus statement from the European Atherosclerosis Society
por: Ginsberg, Henry N, et al.
Publicado: (2021) -
Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease
: Consensus Statement of the European Atherosclerosis Society
por: Nordestgaard, Børge G., et al.
Publicado: (2013) -
Homozygous familial hypercholesterolaemia: new insights and guidance for clinicians to improve detection and clinical management. A position paper from the Consensus Panel on Familial Hypercholesterolaemia of the European Atherosclerosis Society
por: Cuchel, Marina, et al.
Publicado: (2014)